Takeda Pharmaceutical Co Ltd

TAK chart

Takeda Pharmaceutical Co Ltd news

• Takeda Pharmaceutical Co. Ltd. Estimates – TSE:4502

  TradingView · Oct 27, 7:01 AM EDT

• Takeda sets October 29 results date for Takeda Pharmaceutical stock

  ad-hoc-news.de · Oct 27, 4:27 AM EDT

• Takeda Pharmaceutical Company Limited expected to post earnings of JPY134.54 a share - Earnings Preview

  TradingView · Oct 27, 2:16 AM EDT

• 14 analysts lift Takeda Pharmaceutical stock target to USD 20.74

  ad-hoc-news.de · Oct 26, 11:05 AM EDT

• TAK stock has results scheduled for October 29, 2026

  ad-hoc-news.de · Oct 26, 2:43 AM EDT

• Takeda Pharmaceutical Company Limited (TAK) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Oct 26, 1:35 AM EDT

• Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and history

  Yahoo Finance Singapore · Oct 25, 10:51 PM EDT

• 2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein

  Yahoo Finance · Oct 25, 8:00 PM EDT

• Takeda to seek Japan approval for gastric cancer drug next year

  Reuters · Oct 25, 3:02 PM EDT

• Takeda Pharmaceutical Company Limited (4502.T) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Oct 25, 6:17 AM EDT

• Takeda reports cancer trial gains as Takeda Pharmaceutical stock trades at EUR 18.00

  ad-hoc-news.de · Oct 24, 4:22 AM EDT

• Takeda Pharmaceutical (TAK.US) will release its financial report on October 29.

  Moomoo · Oct 23, 10:45 PM EDT

Takeda Pharmaceutical Co Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-09-14
• 6-K6-K2026-08-31
• 6-K6-K2026-08-06
• 6-K6-K2026-07-30
• 6-K6-K2026-07-09
• 6-K6-K2026-07-08
• 6-K6-K2026-06-29
• 6-K6-K2026-06-26
• 6-K6-K2026-06-24
• 6-K6-K2026-06-24
• 6-K6-K2026-06-24
• 20-F20-F2026-06-17

About Takeda Pharmaceutical Co Ltd

Ticker

TAK (NYSE)

Industry

Pharmaceutical Preparations

Headquarters

Tokyo, Japan

SEC CIK

1395064

Frequently asked questions